Kenya’s total of confirmed positive COVID-19 cases hit 192,435 on Saturday, after the Ministry of Health announced 723 new infections from a sample size of 6,881. In a statement to the Press, the Ministry said the new infections posted a 10.5 percent positivity rate. “From the cases 678 are Kenyans while 45 are foreigners. 377 are females and 346 males” the Ministry said on Saturday “The youngest is a seven-month-old baby while the oldest is 98 years.” So far, Kenya has tested 2,050,236 since the first case was announced in March 2021 . Across the country, there are 1,150 patients admitted in various health facilities countrywide, while 4,346 are under the Home-Based Isolation and Care program. “130 patients are in the Intensive Care Unit (ICU), 41 of whom are on ventilatory support and 60 on supplemental oxygen,” the statement notes. Also Read: There are some 29 patients currently under observation. Nairobi led with the highest number of new infections at 229 cases while Nyeri, and Kiambu followed with 86 and 72 new infections respectively. In the rest of the country, the new infections are distributed as follows: Mombasa 67, Busia 27, Nakuru 27, Siaya 26, Machakos 24, Uasin Gishu 24, Kericho 19, Bungoma 18, Nandi 12, Kajiado 11, Makueni 6, Taita Taveta 6, Laikipia 4, Garissa 4, Kisumu 4, Embu 3, Kirinyaga 3, Bomet 2, Kitui 2, Tharaka Nithi 2, Trans Nzoia 2, Kakamega 1, Meru 1, Narok 1, Nyamira 1 and Baringo 1. Meanwhile,1,139 patients are said to have recovered from the disease. 1,084 of the new recoveries are from the Home-Based Isolation and Care program while 55 are from various health facilities across the country. “Total recoveries now stand at 181,682 out of which 145,138 are from the Home Based Care and Isolation program, while 36,544 are from various health facilities countrywide, ” the Ministry said. At the same time, the death toll from the disease rose to 3,760 on Saturday following 6 new fatalities discovered after facility records were audited in July 2021. Video Of The Day: KEMRI scientists examine safety of anti-malarial drugs in first trimester of pregnancy